Analysis of Debt
Total Debt (Carrying Amount)
Regeneron Pharmaceuticals Inc., balance sheet: debt
US$ in thousands
Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11).
| Debt item | Description | The company |
|---|---|---|
| Total debt (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Regeneron Pharmaceuticals Inc.’s total debt increased from 2017 to 2018 and from 2018 to 2019. |
Total Debt (Fair Value)
| Dec 31, 2019 | |
|---|---|
| Selected Financial Data (US$ in thousands) | |
| Finance lease liabilities | 713,900 |
| Convertible senior notes | — |
| Total debt (fair value) | 713,900 |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | 1.00 |
Based on: 10-K (filing date: 2020-02-07).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt: 3.05%
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| 3.05% | 713,900 | 21,774 | |
| Total | 713,900 | 21,774 | |
| 3.05% | |||
Based on: 10-K (filing date: 2020-02-07).
1 US$ in thousands
2 Weighted-average interest rate = 100 × 21,774 ÷ 713,900 = 3.05%